GDF10 is involved in antitumor and Epithelial-mesenchymal transition (EMT) (40, 41)​​, and is often associated with methylation dysregulation in lung cancer, having potential as a therapeutic target (42, 43). This evidence concerns the gene GDF10 and lung cancer.